1. Home
  2. VKTX vs VNOM Comparison

VKTX vs VNOM Comparison

Compare VKTX & VNOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • VNOM
  • Stock Information
  • Founded
  • VKTX 2012
  • VNOM 2013
  • Country
  • VKTX United States
  • VNOM United States
  • Employees
  • VKTX N/A
  • VNOM N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • VNOM Oil & Gas Production
  • Sector
  • VKTX Health Care
  • VNOM Energy
  • Exchange
  • VKTX Nasdaq
  • VNOM Nasdaq
  • Market Cap
  • VKTX 4.6B
  • VNOM 5.0B
  • IPO Year
  • VKTX 2015
  • VNOM 2014
  • Fundamental
  • Price
  • VKTX $42.25
  • VNOM $47.64
  • Analyst Decision
  • VKTX Strong Buy
  • VNOM Strong Buy
  • Analyst Count
  • VKTX 12
  • VNOM 11
  • Target Price
  • VKTX $106.75
  • VNOM $58.18
  • AVG Volume (30 Days)
  • VKTX 3.7M
  • VNOM 831.7K
  • Earning Date
  • VKTX 02-05-2025
  • VNOM 11-04-2024
  • Dividend Yield
  • VKTX N/A
  • VNOM 5.09%
  • EPS Growth
  • VKTX N/A
  • VNOM 2.17
  • EPS
  • VKTX N/A
  • VNOM 2.32
  • Revenue
  • VKTX N/A
  • VNOM $794,412,000.00
  • Revenue This Year
  • VKTX N/A
  • VNOM $9.93
  • Revenue Next Year
  • VKTX N/A
  • VNOM $10.12
  • P/E Ratio
  • VKTX N/A
  • VNOM $20.62
  • Revenue Growth
  • VKTX N/A
  • VNOM 0.51
  • 52 Week Low
  • VKTX $17.23
  • VNOM $30.21
  • 52 Week High
  • VKTX $99.41
  • VNOM $56.76
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 33.93
  • VNOM 29.92
  • Support Level
  • VKTX $37.80
  • VNOM $50.30
  • Resistance Level
  • VKTX $48.55
  • VNOM $50.74
  • Average True Range (ATR)
  • VKTX 2.54
  • VNOM 1.59
  • MACD
  • VKTX -0.45
  • VNOM -0.55
  • Stochastic Oscillator
  • VKTX 30.11
  • VNOM 0.68

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About VNOM Viper Energy Inc.

Viper Energy Inc is focused on owning and acquiring mineral and royalty interests in oil and natural gas properties primarily in the Permian Basin. The Permian Basin is known to have a number of zones of oil and natural gas-bearing rock throughout.

Share on Social Networks: